This week's webinar:

Avoiding the drop zone: GHB use after isolation

with:

Topics include:

• The ways that people of diverse sexualities and genders use GHB
• Harms associated with the use of GHB coming out of Isolation
• Various contexts of GHB use and how it's changed during COVID-19
• Upcoming work ACON is doing around GHB and its use

The webinar series will be held every Friday from 2pm to 2:30pm AEST with a range of guests and topics.

NCCRED is hoping to explore some of the unique challenges currently being experienced by the Alcohol and other Drugs sector amidst the necessity of social distancing and the threat of infection. It’s a great opportunity to share these challenges and reflect on some of the things we’re learning. We hope this will be a useful resource as we step forward into uncertain times.

In this series we’ll dive into some of the immediate problems, research endeavours, and new clinical practices that are emerging during the time of COVID-19 and what life might look like after the pandemic.

This weeks webinar is being held in partnership with:

Webinar schedule:

• Friday 24th April: Elizabeth Knock - St Vincent's Hospital Sydney
• Friday 1st May: Suzie Hudson - NADA
• Friday 8th May: Jennifer Blundell - NSW ADIS
• Friday 15th May: Jack Nagle - Real Drug Talk
• Friday 22nd May: Tony Trimingham - Family Drug Support
• Friday 29th May: Scott Daley, Manager Aboriginal Health & Duran Cox, Aboriginal Counsellor – SVHS
• Friday 12th June: Dr Jessamine Soderstrom, Emergency Physician & Clinical Toxicologist – Royal Perth Hospital
• Friday 19th June: Jack Freestone, Manager of AOD and Mental Health Programs – ACON
• Friday 26th June: Dr Amy Peacock – NDARC, Prof Paul Dietz – Burnet Institute & Dr Mo Hammoud – The Kirby Institute 
• Friday 3rd July: Nicky Bath, Chief Executive Officer – LGBTI Health
• Friday 10th July: Dr Rob Page, General Practitioner

The National Centre for Clinical Research on Emerging Drugs is made up of a consortium of the following four institutions